The new era of aspiration risk: The dilemma of GLP-1 receptor agonists

Journal of Perioperative Nursing · Published 2024-03-08 · DOI 10.26550/2209-1092.1291

Authors being retrieved — see the publisher record. https://doi.org/10.26550/2209-1092.1291

Abstract

There is a new wave of aspiration risk heading towards our operating theatres in the coming years. The popular weight loss drugs, glucagon-like peptide (GLP-1) receptor agonists, are providing us with new dilemmas in fasting guidelines and airway management. What does the anaesthetic team need to know?

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2024

Related articles